Related Experiment Videos
Changes in bacteriology of discharging ears.
Juen-Haur Hwang1, Chih-Kai Chu, Tien-Chen Liu
1Department of Otolaryngology, Poh-Ai Hospital, Lotung, Taiwan.
The Journal of Laryngology and Otology
|November 20, 2002
Summary
Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA), is increasingly common in Taiwanese patients with otorrhoea. This study highlights MRSA prevalence and its susceptibility to key antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Otolaryngology
Background:
- Otorrhoea, or discharging ear, is a common condition requiring bacteriological investigation.
- Understanding the causative pathogens and their antibiotic resistance patterns is crucial for effective treatment.
- Previous studies indicated Pseudomonas aeruginosa as a dominant pathogen in Taiwanese otorrhoea cases.
Purpose of the Study:
- To prospectively investigate the bacteriology of otorrhoea in Taiwanese outpatients.
- To determine the prevalence of Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) in ear infections.
- To assess the antibiotic susceptibility profiles of isolated pathogens, particularly MRSA.
Main Methods:
- Prospective bacteriological study of 161 outpatients with otorrhoea at a Taiwanese teaching hospital.
- Isolation and identification of bacterial pathogens from ear discharge samples.
- Antimicrobial susceptibility testing for recovered isolates, with a focus on MRSA.
Main Results:
- A total of 177 bacterial isolates were recovered, with Staphylococcus aureus (43.5%) being more prevalent than previously reported.
- Pseudomonas sp. was the most common non-Staphylococcus aureus pathogen (28.8%).
- Community-acquired MRSA infections were found in 13.7% of patients, indicating a rising problem in acute otitis externa, granular myringitis, and chronic otitis media.
Conclusions:
- Staphylococcus aureus, including MRSA, has emerged as a significant pathogen in Taiwanese otorrhoea cases.
- MRSA isolates demonstrated high susceptibility to vancomycin, teicoplanin, fusidic acid, and minocycline.
- Further research is recommended to evaluate MRSA susceptibility to ofloxacin.